In-Person Access Only | 8.5 CE/CME Credits & MOC Points
Please read: All programs remain free. Registrations will require a credit card as a cancellation hold. A fee of $99 will only be incurred in the event of a no-show or cancellation within 5 days without written confirmation to the Total Health Program Team. Industry representatives—defined as any individual who is employed by, contracted with, owns, or represents a drug, device, diagnostic, or other healthcare-related commercial entity, regardless of clinical credentials or licensure—are not permitted to attend Total Health events as general attendees. Members of industry must contact exhibits@totalhealthoncology.com
Total Health's 2026 Best of ASCO® Charlotte Conference is an officially licensed Best of ASCO® meeting. This Post ASCO® Review showcases abstracts from highly rated presentations, allowing attendees to engage with the latest research and strategies in oncology education. This accredited meeting will be hosted as an in-person conference only with on-demand access for registered attendees.
Program Chairs:
Robert Ferris, MD, PhD (The University of North Carolina at Chapel Hill)
Kathryn Mileham, MD, FACP, FASCO (Atrium Health Levine Cancer Institute)
Conference Agenda
Saturday, July 18, 2026
8:00 AM
Coffee and Exhibits
8:30 AM
Program Chair Welcome
Robert Ferris, MD, PhD | The University of North Carolina at Chapel Hill
8:40 AM
Colorectal Cancer
Nasfat Shehadeh, MD | Carolina Oncology Specialists
9:10 AM
Non-Colorectal Cancer
Adam Kuykendal, MD | Novant Health
9:40 AM
Breakfast and Exhibits
9:55 AM
Non-CME Breakfast - Natera - Shaping The Future of Precision Medicine
Minetta Liu, MD | Chief Medical Officer of Oncology | Natera
10:40 AM
Head and Neck Cancer
Robert Ferris, MD, PhD | The University of North Carolina at Chapel Hill
11:10 AM
Prostate Cancer
Joseph Kim, MD | Yale Cancer Center
11:40 AM
Non-Prostate Cancer
Mike Harrison, MD | Duke Cancer Institute
12:10 PM
Lunch and Exhibits
12:25 PM
Non-CME Lunch - Abbvie - Pivekimab Sunirine-pvzy and Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Jaypee Singh, PHARMD, BCOP
1:10 PM
Housekeeping and Survey
1:20 PM
Leukemia
Brittany Ragon, MD | Atrium Health Levine Cancer Institute
1:50 PM
Lymphoma
Ariel Perez Perez, MD | Miami Cancer Institute
2:20 PM
Neuroendocrine Tumors
Jennifer Eads, MD | Abramson Cancer Center, Penn Medicine
2:50 PM
Sarcomas and Rare Cancers
Gina D'Amato, MD | Sylvester Comprehensive Cancer Center
3:20 PM
Adjourn
Sunday, July 19, 2026
7:30 AM
Coffee and Exhibits
8:00 AM
Program Chair Welcome
Kathryn Mileham, MD, FACP, FASCO | Atrium Health Levine Cancer Institute
8:10 AM
Small Cell Lung Cancer
Neal Ready, MD, PhD | Duke Cancer Institute
8:40 AM
Non-Small Cell Lung Cancer
Kathryn Mileham, MD, FACP, FASCO | Atrium Health Levine Cancer Institute
9:10 AM
The Emerging Role of PD-1 × VEGF Bispecific Antibodies in NSCLC
Neal Ready, MD, PhD | Duke Cancer Institute
9:30 AM
Breakfast and Exhibits
9:55 AM
Non-CME Breakfast - Pfizer - Learn About a Treatment Option for Patients With HR+/HER2+ mBC
Priya Rudolph, MD, PhD | Augusta University
10:40 AM
Multiple Myeloma
Henry Fung, MD | Fox Chase Cancer Center -Temple Health
11:10 AM
Melanoma
Nina Mathew, MD | Kansas University Medical Center
11:40 AM
Ovarian Cancer
Jubilee Brown, MD | Atrium Health Levine Cancer Institute
12:10 PM
Lunch and Exhibits
12:25 PM
Non-CME Lunch - Abbvie Elahere - Mirvetuximab Soravtansine: A FRα Targeted ADC for Platinum Resistant Ovarian Cancer
Lindsay McGrath | AbbVie
1:10 PM
Survivorship
Sonia Amin Thomas, PharmD | Philadelphia College of Osteopathic Medicine
1:40 PM
Early-Stage Breast Cancer
Elyse Lower, MD | University of Cincinnati
2:10 PM
Metastatic Breast Cancer
Antoinette Tan, MD, FASCO | Atrium Health Levine Cancer Institute
2:40 PM
Adjourn
Agenda Subject To Change. All times are EST.
-
Integrate new evidence into everyday clinical practice, thereby improving the quality of care being delivered to patients living with and beyond cancer.
Implement practice changes in a variety of treatment options for solid tumors, including lung, breast, melanoma, colorectal, non-colorectal GI, and GU cancers
Stimulate innovative strategies for new and additional research related to treatment and prevention
Recognize the implications for practice change in both the academic and community practice settings
-
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Nurses (ANCC) Credit Designation
Amedco LLC designates this activity for a maximum of 8.5 ANCC contact hours.
Physicians (ACCME) Credit Designation
Amedco LLC designates this live activity for a maximum of 8.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacists and Pharmacy Technicians (ACPE) Credit Designation
Amedco LLC designates this activity for a maximum of 8.5 knowledge-based CPE contact hours.
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 45 days of your participation in the activity to meet the deadline for submission to CPE Monitor.
American Board of Internal Medicine (ABIM) MOC Credit
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 8.5 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. You must request your certificate within 45 days of the activity to meet the deadline for submission to PARS.
-
Free registration for all healthcare providers
Expert sessions that present the most clinically relevant data, research, and clinical strategies
Enduring video content for watching at your leisure
Real-time discussion and debate
Networking with peers, colleagues, and medical professionals
Access to the latest industry information and resources
Catered meals through-out the program